Clinical trials

  • CYTARABINE for Acute myeloid leukaemia (FLT3 mutation)
  • BOTULINUM TOXIN TYPE A for Chronic pelvic pain syndrome
  • peginterferon beta-1a for Relapsing-remitting multiple sclerosis
  • GEDATOLISIB for Metastatic castration-resistant prostate cancer
  • SELUMETINIB for Neurofibromatosis type 1 (NF1) with plexiform neurofibromas
  • POSACONAZOLE for Invasive fungal infection
  • OCTREOTIDE for Neuroendocrine tumor (grade I-II)
  • HUMANISED IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7 AND CXCL8 for Hidradenitis suppurativa (moderate to severe)
  • 1-[6-ETHYL-8-FLUORO-4-METHYL-3-(3-METHYL-1,2,4-OXADIAZOL-5-YL)QUINOLIN-2-YL]-N-(OXAN-4-YL)PIPERIDIN-4-AMINE for Major Depressive Disorder
  • ACALABRUTINIB for Chronic lymphocytic leukaemia | Small lymphocytic lymphoma
  • FICLATUZUMAB for Head and neck squamous cell carcinoma (HPV-negative)
  • SERALUTINIB for Pulmonary arterial hypertension